ozempic to glp-1 alternative transition programs Weight-loss drugs such as were in the headlines a lot in 2025 – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ From 'companion foods' to 'Nature's

While research on GLP-1 therapies and inflammatory arthritis is still evolving, collaboration between endocrinology, primary care, and rheumatology can reduce uncertainty

These are the popular diabetes and weight-loss drugs such as Ozempic, Wegovy, Rybelsus (semaglutide), Mounjaro, Zepbound (tirzepatide), Trulicity (dulaglutide), Victoza and Saxenda (liraglutide), and Byetta or Bydureon (exenatide)

More on, ADA and AACE Guidelines prefer GLP1RA over DPP4i for patients with established ASCVD or indicators of high ASCVD risk, CKD 3, or heart failure 1

That earned her a place in the Sports Illustrated swimsuit edition and on ABC's "Dancing With The Stars." She now has more than 9 million social media followers and uses her videos to speak openly on body positivity and the issues she faces as a female athlete

Compounders can make drugs when a patients needs cant be met by an existing FDA-approved drugsay, theyre allergic to a dye or binding agent in it or they cant swallow pills or take it in whatever form is availableor when theres a shortage of an FDA-approved drug

But, the female body needs hormonal balance of estrogen and testosterone, so GLP-1 drugs can interfere with the brains chemical messengers